Last Name


Search Results to Paul C. Toren

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Toren, Paul

keywords Drug Metabolism
keywords Drug Development
research overview Dr. Toren has a broad background in a variety of aspects of Mass Spectrometry with a current focus on small molecule LCMS. He's facilitated numerous projects in fields of drug development (both non-clinical and clinical research), bioanalysis and drug metabolism. Current projects include analysis of antidepressants, neurotransmitters and medications related to ADHD, autism and related disease states.

One or more keywords matched the following items that are connected to Toren, Paul

Item TypeName
Concept Alamethicin
Concept Amines
Concept Amino Acids
Concept Angiotensin-Converting Enzyme Inhibitors
Concept Anti-Ulcer Agents
Concept Hypolipidemic Agents
Concept alpha-2-Antiplasmin
Concept Antitubercular Agents
Concept Aryl Hydrocarbon Hydroxylases
Concept Benzazepines
Concept Binding Sites
Concept Blood Proteins
Concept Carbon Radioisotopes
Concept Cyanogen Bromide
Concept Diltiazem
Concept Dose-Response Relationship, Drug
Concept Drug Interactions
Concept Drug Evaluation, Preclinical
Concept Drug Stability
Concept Pharmaceutical Preparations
Concept Enkephalin, Leucine
Concept Enzyme Inhibitors
Concept Fibrinolysin
Concept Glucuronates
Concept Insulin
Concept Peptidyl-Dipeptidase A
Concept Omeprazole
Concept Peptide Fragments
Concept Pimozide
Concept Protease Inhibitors
Concept Pyridines
Concept Recombinant Proteins
Concept Rifampin
Concept Sulfates
Concept Sulfhydryl Compounds
Concept Ticlopidine
Concept Antipsychotic Agents
Concept Trimethoprim
Concept Trypsin
Concept Tyrosine
Concept Uridine Diphosphate Glucuronic Acid
Concept Gemfibrozil
Concept Neprilysin
Concept Trimethoprim, Sulfamethoxazole Drug Combination
Concept Cytochrome P-450 CYP2D6
Concept Glucuronides
Concept Cytochrome P-450 CYP3A
Concept 2-Pyridinylmethylsulfinylbenzimidazoles
Concept Proton Pump Inhibitors
Concept Peptidomimetics
Concept Esomeprazole
Concept Lansoprazole
Concept Cytochrome P-450 Enzyme Inhibitors
Concept Cytochrome P-450 CYP2D6 Inhibitors
Concept Cytochrome P-450 CYP2C8
Concept Cytochrome P-450 CYP2C9
Concept Cytochrome P-450 CYP2C19
Academic Article An evaluation of the dilution method for identifying metabolism-dependent inhibitors of cytochrome P450 enzymes.
Academic Article The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.
Academic Article High-resolution mass spectrometry elucidates metabonate (false metabolite) formation from alkylamine drugs during in vitro metabolite profiling.
Academic Article Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions.
Academic Article Tyr1-?[( Z)CF-CH]-Gly2 Fluorinated Peptidomimetic Improves Distribution and Metabolism Properties of Leu-Enkephalin.
Academic Article Disposition and metabolism of 14C-rifapentine in healthy volunteers.
Academic Article Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
Academic Article Quantification of a dual angiotensin I-converting enzyme-neutral endopeptidase inhibitor and the active thiol metabolite in dog plasma by high-performance liquid chromatography with ultraviolet absorbance detection.
Academic Article The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites.
Academic Article Simultaneous quantification of trimethoprim metabolites in pediatric plasma.

Search Criteria
  • Drug
  • Development